232 related articles for article (PubMed ID: 26547344)
1. [Pretreatment with dexmedetomidine ameliorates renal inflammation and oxidative stress in rats with lipopolysaccharide-induced sepsis and acute kidney injury].
Chen YJ; Gong CL; Tan F; Zhou SL
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Oct; 35(10):1472-5. PubMed ID: 26547344
[TBL] [Abstract][Full Text] [Related]
2. Effects of dexmedetomidine pretreatment on rats with sepsis-induced acute kidney injury and miR-146a expression.
Ni J; He J; Kang L; Zhong Z; Wang L; Yin S
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):93-98. PubMed ID: 32415933
[TBL] [Abstract][Full Text] [Related]
3. Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.
Chen JH; Yu GF; Jin SY; Zhang WH; Lei DX; Zhou SL; Song XR
Int J Clin Exp Pathol; 2015; 8(9):10752-9. PubMed ID: 26617786
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine restores septic renal function via promoting inflammation resolution in a rat sepsis model.
Qiu R; Yao W; Ji H; Yuan D; Gao X; Sha W; Wang F; Huang P; Hei Z
Life Sci; 2018 Jul; 204():1-8. PubMed ID: 29733849
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Alleviates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting p75NTR-Mediated Oxidative Stress and Apoptosis.
Wang Z; Wu J; Hu Z; Luo C; Wang P; Zhang Y; Li H
Oxid Med Cell Longev; 2020; 2020():5454210. PubMed ID: 33194004
[TBL] [Abstract][Full Text] [Related]
7. Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice.
Ning Q; Liu Z; Wang X; Zhang R; Zhang J; Yang M; Sun H; Han F; Zhao W; Zhang X
Neurol Res; 2017 Apr; 39(4):357-366. PubMed ID: 28173746
[TBL] [Abstract][Full Text] [Related]
8. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture.
Kiyonaga N; Moriyama T; Kanmura Y
Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats.
Chen Y; Luan L; Wang C; Song M; Zhao Y; Yao Y; Yang H; Ma B; Fan H
Nitric Oxide; 2019 Apr; 85():1-9. PubMed ID: 30659917
[TBL] [Abstract][Full Text] [Related]
10. Effects of dexmedetomidine on sepsis-induced liver injury in rats.
Li XK; Yang SC; Bi L; Jia Z
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):177-183. PubMed ID: 31389589
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway.
Kang K; Gao Y; Wang SC; Liu HT; Kong WL; Zhang X; Huang R; Qi ZD; Zheng JB; Qu JD; Liu RJ; Liu YS; Wang HL; Yu KJ
Biomed Pharmacother; 2018 Oct; 106():210-216. PubMed ID: 29960167
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H
J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats.
Tan F; Chen Y; Yuan D; Gong C; Li X; Zhou S
Biomed Rep; 2015 May; 3(3):365-370. PubMed ID: 26137237
[TBL] [Abstract][Full Text] [Related]
15. S-allyl cysteine protects against lipopolysaccharide-induced acute kidney injury in the C57BL/6 mouse strain: Involvement of oxidative stress and inflammation.
Khajevand-Khazaei MR; Azimi S; Sedighnejad L; Salari S; Ghorbanpour A; Baluchnejadmojarad T; Mohseni-Moghaddam P; Khamse S; Roghani M
Int Immunopharmacol; 2019 Apr; 69():19-26. PubMed ID: 30665040
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
Zi SF; Li JH; Liu L; Deng C; Ao X; Chen DD; Wu SZ
Int Immunopharmacol; 2019 Nov; 76():105898. PubMed ID: 31520992
[TBL] [Abstract][Full Text] [Related]
17. Effects of dexmedetomidine on postoperative cognitive function of sleep deprivation rats based on changes in inflammatory response.
Guo B; Chen C; Yang L; Zhu R
Bioengineered; 2021 Dec; 12(1):7920-7928. PubMed ID: 34622713
[TBL] [Abstract][Full Text] [Related]
18. [Effects of Dexmedetomidine on the levels of proinflammatory mediators IL-1βand TNF-α in pulmonary ischemia/reperfusion injury rats and the mechanisms].
Xiang BQ; He JB; Gao H; Luo ZY; Dai YY; Wang WT
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):415-419. PubMed ID: 29926585
[TBL] [Abstract][Full Text] [Related]
19. The role of the vagus nerve on dexmedetomidine promoting survival and lung protection in a sepsis model in rats.
Li Y; Wu B; Hu C; Hu J; Lian Q; Li J; Ma D
Eur J Pharmacol; 2022 Jan; 914():174668. PubMed ID: 34863997
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine attenuates lipopolysaccharide-induced renal cell fibrotic phenotypic changes by inhibiting necroinflammation via activating α
Sun Q; Kamath P; Sun Y; Liang M; Wu L; Chang E; Chen Q; Alam A; Liu Y; Zhao H; Ma D
Biomed Pharmacother; 2024 May; 174():116462. PubMed ID: 38513598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
